Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Viemed Healthcare Inc VMD

Viemed Healthcare, Inc. through its subsidiaries, is a provider of home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The Company’s service offerings are focused on effective in-home treatment with clinical practitioners providing therapy and counselling to patients in their homes using cutting edge technologies. The Company’s products and services... see more

NDAQ:VMD - Post Discussion

Viemed Healthcare Inc > VMD publishes study demonstrating the benefits of NIVH
View:
Post by davgro on Jul 05, 2022 4:48pm

VMD publishes study demonstrating the benefits of NIVH

LAFAYETTE, La., July 05, 2022 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD and TSX:VMD.TO), a national leader in respiratory care and technology-enabled home medical equipment services, announced a third peer-reviewed and published study demonstrating the benefits of non-invasive ventilation at home (“NIVH”). The study, titled “Early Initiation of Non-Invasive Ventilation at Home Improves Survival and Reduces Healthcare Costs in COPD Patients with Chronic Hypercapnic Respiratory Failure: A Retrospective Cohort Study” was published in Respiratory Medicine, an internationally renowned scientific journal devoted to respiratory medical research.

Continue Reading...

https://www.globenewswire.com/news-release/2022/07/05/2474404/0/en/Viemed-Announces-Publication-of-Peer-Reviewed-NIVH-Study-Finding-Treatment-Reduces-Healthcare-Costs-and-Saves-Lives.html
Comment by Tropicalsun on Jul 05, 2022 6:16pm
So this is the third published study where measureable medical research shows that lives are saved, hospital readmission is reduced and money per patient is saved. Now it may not be a huge amount of money being saved, but the main objective should be that it saves lives and keeps these patients out of the hospital. Can someone explain to me what Viemed is expecting to achieve with these studies ...more  
Comment by lscfa on Jul 05, 2022 8:03pm
Co. should be doing a study of NIVH vs BiPaP if it wants more docs to prescribe NIVH.      Throughout its comments Sleep Management contends that the NHV is inherently better than other devices at providing respiratory assistance, but studies have shown that an NHV is not medically necessary in many circumstances. [footnote 45] Medicare requirements obligated our medical ...more  
Comment by besttobe on Jul 06, 2022 10:33am
Tropic wrote "Can someone explain to me what Viemed is expecting to achieve with these studies? " Too justify their core revenue NIV for growth.  Also to avoid the penalty they continue to face now and in the future for over subscibing NIV per OIG report. They are still exposed to losing approx/est of $9 mil cash in penalties for over subscribing now. At this time, they are waiting ...more  
Comment by LongTerm3 on Jul 06, 2022 11:55am
By the last three posts, you guys have a complete understanding of what Viemed does.  Disclosure - I am long for years. Why don't you short the stock for your account?
Comment by Tropicalsun on Jul 06, 2022 9:53pm
LongTerm3, is there a problem with my post? I was being sarcastic about how many of the same studies have to be written before people understand the benefits to non invasive vent treatment.  Disclosure - I am long on the stock also, who really cares how long either of us hold the stock? You clearly have a huge bias towards the company, any negative comments and you quickly get your panties ...more  
Comment by JackLambert on Jul 06, 2022 10:01pm
Tomorrow we might see $6US and $8 Canadian. 
Comment by stockfy on Jul 08, 2022 7:11am
The purpose is two fold. This report is another key argument that supports VMD during the OIG report. Additionally, it opens the road for new contract wins.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities